Clinical Trial Update: A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naïve Acute Myeloid Leukemia (AML): DLIT-AML [Phase 1]

View source ↗

Summary

Phase 1B investigator-initiated study evaluating safety and tolerability of dexamethasone in combination with venetoclax-based low-intensity therapy for treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Venetoclax (venetoclax)

Snippet

Sponsor: University of Vermont | Conditions: AML - Acute Myeloid Leukemia | Phase 1 | Status: ENROLLING_BY_INVITATION